Evidence map›Paper›PMID 37089035›Full record

ArticleTurkish journal of ophthalmology2023

Different Cases, Different Manifestations of Post-COVID-19 Retinal Artery Occlusion: A Case Series.

Özgür Yalçınbayır, Gamze Uçan Gündüz, Funda Coşkun, Bahattin Hakyemez, Selim Doğanay

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Özgür YalçınbayırBursa Uludağ University Faculty of Medicine, Department of Ophthalmology, Bursa, Türkiye.ORCID 0000-0002-1219-8304
Gamze Uçan GündüzBursa Uludağ University Faculty of Medicine, Department of Ophthalmology, Bursa, Türkiye.ORCID 0000-0002-5458-1686
Funda CoşkunBursa Uludağ University Faculty of Medicine, Department of Pulmonology, Bursa, Türkiye.ORCID 0000-0003-3604-8826
Bahattin HakyemezBursa Uludağ University Faculty of Medicine, Department of Radiology, Bursa, Türkiye.ORCID 0000-0002-3425-0740
Selim DoğanayBursa Uludağ University Faculty of Medicine, Department of Ophthalmology, Bursa, Türkiye.ORCID 0000-0002-6142-1875
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a procoagulant disease that increases the risk of clinically evident thrombotic complications. Herein we present 3 cases with different retinal artery occlusions that emerged soon after the diagnosis of COVID-19. The first patient had central retinal artery occlusion (CRAO) that resulted in visual loss in one eye. The second patient had inflammatory peripheral retinal artery occlusion, vasculitis, and uveitis which did not affect vision. The third patient presented with CRAO following the progression from orbital cellulitis to orbital apex syndrome. Interestingly, CRAO progressed to internal carotid artery occlusion in this case within days and resulted in monocular visual loss. Variations in the underlying pathophysiology and the characteristics of individual immune responses in patients with COVID-19 may be factors that determine differences in clinical manifestations. This article aims to describe different presentations of COVID-19-related retinal artery occlusions and discuss possible pathophysiological aspects.

Indexed as

COVID-19Retinal Artery OcclusionBlindnessHumansRetinaCOVID-19retinal artery occlusionSARS-CoV-2

Identifiers

PMID37089035
PMCPMC10127544
OpenAlexW4366583913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.